Bromma, Sweden

Malin Oreback

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Malin Oreback: Innovator in Blister Pack Technology

Introduction

Malin Oreback is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of packaging technology, particularly with his innovative blister pack device. His work is essential in improving the efficiency of storing and dispensing dosage units.

Latest Patents

Malin Oreback holds a patent for a blister pack device. This invention relates to a device designed for storing and dispensing a dosage unit. The device includes a container with an opening for receiving a blister pack. It features a dispensing mechanism that ejects a dosage unit from the blister pack. The mechanism consists of a lever arm that is pivotally mounted on the container, along with a cavity for receiving the ejected dosage unit. The lever arm has a first open position that allows the blister pack to be positioned underneath it and a second lowered position for ejecting the dosage unit into the cavity.

Career Highlights

Malin Oreback is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to apply his innovative ideas in a practical setting, contributing to advancements in healthcare and medication delivery systems.

Collaborations

Malin has collaborated with several talented individuals in his field, including Maria Benktzon and Thomas Nilsson. These collaborations have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Malin Oreback's contributions to blister pack technology exemplify the importance of innovation in the pharmaceutical industry. His patent for a blister pack device showcases his commitment to improving medication delivery systems. Through his work at AstraZeneca AB and collaborations with colleagues, he continues to make a significant impact in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…